{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.26","value":"1.0"},{"groupId":"OG001","spread":"1.02","value":"0.6"},{"groupId":"OG002","spread":"1.21","value":"0.7"},{"groupId":"OG003","spread":"1.21","value":"0.4"}]}],"title":"Week 4 Minus Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.28","value":"1.7"},{"groupId":"OG001","spread":"1.58","value":"1.0"},{"groupId":"OG002","spread":"1.25","value":"1.1"},{"groupId":"OG003","spread":"1.59","value":"1.5"}]}],"title":"Week 7 Minus Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.39","value":"1.7"},{"groupId":"OG001","spread":"1.42","value":"1.2"},{"groupId":"OG002","spread":"1.37","value":"1.2"},{"groupId":"OG003","spread":"1.44","value":"1.5"}]}],"title":"Week 10 Minus Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.27","value":"2.1"},{"groupId":"OG001","spread":"1.51","value":"1.2"},{"groupId":"OG002","spread":"1.32","value":"1.3"},{"groupId":"OG003","spread":"1.65","value":"1.6"}]}],"title":"Week 13 Minus Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.67","value":"1.7"},{"groupId":"OG001","spread":"1.64","value":"1.2"},{"groupId":"OG002","spread":"1.44","value":"1.6"},{"groupId":"OG003","spread":"1.41","value":"1.9"}]}],"title":"Week 16 Minus Baseline"}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"60"},{"groupId":"OG002","value":"58"},{"groupId":"OG003","value":"57"}],"units":"Participants"}],"description":"To compare the effects of the 3 different epoetin alfa dosing schedules and an every-3-weeks darbepoetin alfa schedule","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive Epoetin alfa 40,000 units subcutaneously every week for 15 weeks (15 doses)","id":"OG000","title":"Epoetin Alfa - 40k Weekly"},{"description":"Patients receive Epoetin alfa 80,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG001","title":"Epoetin Alfa - 80k Every 3 Weeks"},{"description":"Patients receive Epoetin alfa 120,000 units subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG002","title":"Epoetin Alfa - 120k Every 3 Weeks"},{"description":"Patients receive Darbepoetin alfa 500 micrograms (mcg) subcutaneously every 3 weeks for 15 weeks (5 doses)","id":"OG003","title":"Darbepoetin Alfa - 500 mcg Every 3 Weeks"}],"paramType":"MEAN","populationDescription":"All patients that were evaluable per protocol and had hemoglobin data at baseline, week 4, 7, 10, 13 or 16.","reportingStatus":"POSTED","timeFrame":"Baseline and Week 4, 7, 10, 13, 16","title":"Weekly Change in Hemoglobin Levels","type":"SECONDARY","unitOfMeasure":"g/dL"}